I'm a partner in <a href=" https://www.ivor-reisbegeleiding.nl/buy-betamethasone-cream-online-uk.pdf ">buy betamethasone valerate foam</a> This stock has become li&#8217;l more than a tool for the insiders/institutions/funds who pretty much own the float outright to shovel shares back and forth to bump the price in order to trap and loot short sellers. the numbers don&#8217;t add up. No one is applying affordability to the equation. The CEO guesstimates 15,000 afflicted with HoFH worldwide (more&#8217;n double the FDA estimate of one in a million). Based upon 2009 IRS statistics roughly one in two hundred Americans could (if they chose) afford a 300K prescription, course we’re more affluent than most in the world, USA GDP per capita is $49,800 (2012 est.), World GDP per capita is $12,400 (2012 est.), accordingly you’d have to assume a much smaller ratio able to afford it on a worldwide basis, assuming one in a thousand (probably still far too high) persons could afford the prescription (and choose it over less expensive treatments), you’d have a grand total of 15 customers and 4.5 million in annual revenue&#8230;don&#8217;t be fooled by short term results, it&#8217;s an accounting game, bottom line they&#8217;re still losing money&#8230;with a 2,500 million market cap created of BS and price fixing.